Free tool
Stocks far below their 52-week high
We cover 182 companies trading at least 50% below their own 52-week high. The median market value in the group is $300.20M. Across the group, the median move over the past trading day is −0.10%. 8% of the 178 with a 200-day average trade above it. Price change over the past year runs from −75.7% to +47.0% across the middle 80 percent of the group, with a median of −42.3%.
Other lists in this group
Table
182 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| GILD34.SA | Gilead Sciences, Inc. | $184.15B | Large cap | −79.11% |
| VRTX34.SA | Vertex Pharmaceuticals Incorporated | $139.70B | Large cap | −83.18% |
| MDTC34.SA | Medtronic plc | $118.37B | Large cap | −75.74% |
| M1CK34.SA | McKesson Corporation | $104.59B | Large cap | −92.49% |
| ESL.DE | EssilorLuxottica Société anonyme | $85.76B | Large cap | −39.11% |
| EL.PA | EssilorLuxottica Société anonyme | $85.31B | Large cap | −38.15% |
| C1IC34.SA | The Cigna Group | $73.39B | Large cap | −85.33% |
| B1SX34.SA | Boston Scientific Corporation | $70.04B | Large cap | −89.24% |
| BSX | Boston Scientific Corporation | $69.81B | Large cap | −54.50% |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% |
| A1GI34.SA | Agilent Technologies, Inc. | $39.64B | Large cap | −77.37% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% |
| Z1TS34.SA | Zoetis Inc. | $32.03B | Large cap | −52.31% |
| A1LN34.SA | Alnylam Pharmaceuticals, Inc. | $31.78B | Large cap | −49.35% |
| SMMT | Summit Therapeutics Inc. | $11.35B | Large cap | −42.63% |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% |
| I1QV34.SA | IQVIA Holdings Inc. | $10.82B | Large cap | −67.19% |
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
| NTLA | Intellia Therapeutics, Inc. | $1.89B | Small cap | +15.50% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.87B | Small cap | −28.63% |
| INSP | Inspire Medical Systems, Inc. | $1.79B | Small cap | −33.04% |
| 4DX.AX | 4DMedical Limited | $1.59B | Small cap | +669.79% |
| AAPG | Ascentage Pharma Group Internat | $1.58B | Small cap | −59.18% |
| ATEC | Alphatec Holdings, Inc. | $1.45B | Small cap | −41.78% |
| P1RG34.SA | Perrigo Company plc | $1.37B | Small cap | −59.77% |
| MLTX | MoonLake Immunotherapeutics | $1.32B | Small cap | −71.82% |
| VOR | Vor Biopharma Inc. | $1.30B | Small cap | −40.82% |
| PRCT | PROCEPT BioRobotics Corporation | $1.21B | Small cap | −48.36% |
| WVE | Wave Life Sciences, Inc. | $1.03B | Small cap | −48.12% |
| QDEL | QuidelOrtho Corporation | $1.02B | Small cap | −46.31% |
| ARDX | Ardelyx, Inc. | $975.95M | Small cap | −38.13% |
| OLMA | Olema Pharmaceuticals, Inc. | $949.35M | Small cap | +89.02% |
| AHG | Akso Health Group | $848.14M | Small cap | −43.10% |
| AHCO | AdaptHealth Corp. | $771.43M | Small cap | −38.44% |
| D2OC34.SA | Doximity, Inc. | $733.94M | Small cap | −65.76% |
| CTMX | CytomX Therapeutics, Inc. | $723.43M | Small cap | +60.39% |
| OCS | Oculis Holding AG | $720.20M | Small cap | −25.14% |
| PHR | Phreesia, Inc. | $716.58M | Small cap | −63.74% |
| SSII | SS Innovations International, Inc. | $715.38M | Small cap | −50.55% |
| PHAT | Phathom Pharmaceuticals, Inc. | $709.50M | Small cap | −29.50% |
| ALLO | Allogene Therapeutics, Inc. | $704.80M | Small cap | +75.86% |
| EVT.DE | Evotec SE | $694.87M | Small cap | −45.75% |
| PROK | ProKidney Corp. | $694.58M | Small cap | −30.12% |
| EVO | Evotec SE | $693.01M | Small cap | −44.13% |
| 2HQ0.DE | Tilray Brands, Inc. | $657.67M | Small cap | −67.56% |
| TLRY.TO | Tilray Brands, Inc. | $640.36M | Small cap | +240.00% |
| TLRY | Tilray Brands, Inc. | $638.38M | Small cap | −66.13% |
| CU6.AX | Clarity Pharmaceuticals Ltd | $628.73M | Small cap | −25.63% |
| ALT | Altimmune, Inc. | $604.95M | Small cap | −14.17% |
| MPLT | MapLight Therapeutics, Inc. | $596.42M | Small cap | −29.88% |
| CRW.L | Craneware plc | $588.10M | Small cap | −40.83% |
| SPRY | ARS Pharmaceuticals, Inc. | $568.84M | Small cap | −55.13% |
| EVH | Evolent Health, Inc. | $556.25M | Small cap | −48.86% |
| 019175.KS | Shinpoong Pharmaceutical Co.,Ltd | $517.68M | Small cap | −40.58% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $507.75M | Small cap | −41.46% |
| EVMN | Evommune, Inc. | $500.47M | Small cap | −30.25% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | $498.50M | Small cap | −90.91% |
| 4592.T | SanBio Company Limited | $495.75M | Small cap | −57.08% |
| CGC | Canopy Growth Corporation | $492.21M | Small cap | −31.46% |
| WEED.TO | Canopy Growth Corporation | $489.98M | Small cap | −31.25% |
| RZLT | Rezolute, Inc. | $485.31M | Small cap | −30.00% |
| 317450.KS | MYUNGIN PHARM | $482.84M | Small cap | −55.96% |
| CAPR | Capricor Therapeutics, Inc. | $481.97M | Small cap | +49.76% |
| AGY.L | Allergy Therapeutics plc | $481.91M | Small cap | −30.00% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | $481.69M | Small cap | −1.57% |
| BIOA | BioAge Labs, Inc. | $451.63M | Small cap | +107.59% |
| CMPX | Compass Therapeutics, Inc. | $437.61M | Small cap | −25.91% |
| EYPT | EyePoint, Inc. | $430.20M | Small cap | −57.85% |
| LXEO | Lexeo Therapeutics, Inc. | $420.90M | Small cap | +3.30% |
| UPB | Upstream Bio, Inc. | $390.52M | Small cap | −57.31% |
| ONCO3.SA | Oncoclínicas do Brasil Serviços Médicos S.A. | $381.80M | Small cap | −33.79% |
| LYEL | Lyell Immunopharma, Inc. | $362.68M | Small cap | +37.32% |
| N3B.F | Anbio Biotechnology | $361.87M | Small cap | −83.42% |
| STRO | Sutro Biopharma, Inc. | $355.50M | Small cap | +138.11% |
| NNNN | Anbio Biotechnology | $343.67M | Small cap | −83.55% |
| 249420.KS | Ildong Pharmaceutical Co., Ltd. | $329.08M | Small cap | −40.38% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | $316.56M | Small cap | +47.70% |
| RAC.AX | Racura Oncology Ltd | $312.81M | Small cap | +87.39% |
| YDES | YD Bio Ltd | $307.41M | Small cap | −63.83% |
| EBS | Emergent BioSolutions Inc. | $306.10M | Small cap | −30.50% |
| BCYC | Bicycle Therapeutics plc | $304.03M | Small cap | −37.79% |
| AVXL | Anavex Life Sciences Corp. | $300.34M | Small cap | −65.71% |
| 4894.T | Cuorips Inc. | $300.07M | Small cap | −15.38% |
| MYGN | Myriad Genetics, Inc. | $298.43M | Small cap | −47.39% |
| TRDA | Entrada Therapeutics, Inc. | $296.70M | Small cap | +23.24% |
| FULC | Fulcrum Therapeutics, Inc. | $294.51M | Small cap | −41.78% |
| 003000.KS | Bukwang Pharmaceutical Co., Ltd. | $294.43M | Small cap | +26.14% |
| NMRA | Neumora Therapeutics, Inc. | $293.12M | Small cap | −11.36% |
| 0120G0.KS | Samyang Biopharm | $292.45M | Small cap | +79.14% |
| TTRX | Turn Therapeutics Inc. | $292.44M | Small cap | +37.57% |
| CV | CapsoVision, Inc. | $291.27M | Small cap | +46.97% |
| 7777.T | 3-D Matrix, Ltd. | $289.93M | Small cap | +68.69% |
| EMBC | Embecta Corp. | $285.00M | Small cap | −64.70% |
| SION | Sionna Therapeutics, Inc. | $282.58M | Small cap | −75.45% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| 950210.KS | Prestige BioPharma Limited | $268.90M | Small cap | −55.91% |
| IVVD | Invivyd, Inc. | $265.78M | Small cap | +3.52% |
| RXST | RxSight, Inc. | $265.36M | Small cap | −25.38% |
| NAGE | Niagen Bioscience, Inc. | $260.44M | Small cap | −66.22% |
| NERV | Minerva Neurosciences, Inc. | $259.27M | Small cap | +129.11% |
| LAB | Standard BioTools Inc. | $255.18M | Small cap | −49.08% |
| AKBA | Akebia Therapeutics, Inc. | $251.20M | Small cap | −69.88% |
| 4593.T | Healios K.K. | $239.21M | Small cap | −41.63% |
| PEPG | PepGen Inc. | $237.21M | Small cap | +159.68% |
| TNXP | Tonix Pharmaceuticals Holding Corp. Common Stock | $233.94M | Small cap | −57.61% |
| HLS.AX | Healius Limited | $233.27M | Small cap | −50.55% |
| TARA | Protara Therapeutics, Inc. | $231.06M | Small cap | +21.05% |
| TSND.TO | TerrAscend Corp. | $228.23M | Small cap | −44.44% |
| ORGO | Organogenesis Holdings Inc. | $225.18M | Small cap | −63.84% |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% |
| SIGA | SIGA Technologies, Inc. | $220.58M | Small cap | −57.93% |
| KROS | Keros Therapeutics, Inc. | $220.48M | Small cap | −28.35% |
| NBP | NovaBridge Biosciences | $216.26M | Small cap | −58.44% |
| ZJYL | Jin Medical International Ltd. | $208.31M | Small cap | −82.97% |
| ARMP | Armata Pharmaceuticals, Inc. | $202.64M | Small cap | +123.36% |
| KRRO | Korro Bio, Inc. | $201.45M | Small cap | −36.61% |
| AIRS | AirSculpt Technologies, Inc. | $196.10M | Small cap | −57.30% |
| HUMA | Humacyte, Inc. | $189.35M | Small cap | −55.45% |
| AIDX.TO | Healwell AI Inc. | $189.11M | Small cap | −40.08% |
| MYX.AX | Mayne Pharma Group Limited | $182.17M | Small cap | −37.38% |
| CNTN | Canton Strategic Holdings, Inc. | $177.69M | Small cap | −55.04% |
| SPRB | Spruce Biosciences, Inc. | $176.69M | Small cap | +721.93% |
| WW | WW International, Inc. | $175.98M | Small cap | −45.96% |
| QSI | Quantum-Si incorporated | $173.05M | Small cap | −31.84% |
| SANION.ST | Saniona AB (publ) | $171.29M | Small cap | −12.37% |
| MENS | Jyong Biotech Ltd. | $170.30M | Small cap | −95.62% |
| PGC.AX | Paragon Care Limited | $166.54M | Small cap | −58.24% |
| NYXH | Nyxoah SA | $164.12M | Small cap | −73.74% |
| ALSEN.PA | Sensorion SA | $164.03M | Small cap | −14.20% |
| 504A.T | Innovacell Inc. | $162.36M | Small cap | −45.71% |
| LFMD | LifeMD, Inc. | $156.17M | Small cap | −49.45% |
| TNYA | Tenaya Therapeutics, Inc. | $156.11M | Small cap | −36.71% |
| SPRC | SciSparc Ltd. | $154.36M | Small cap | −82.42% |
| EBR.AX | EBR Systems, Inc. | $154.30M | Small cap | −78.74% |
| OTLK | Outlook Therapeutics, Inc. | $151.26M | Small cap | −73.76% |
| 003520.KS | Yungjin Pharm. Co., Ltd. | $150.88M | Small cap | −43.89% |
| OWLT | Owlet, Inc. | $150.78M | Small cap | −28.43% |
| AARD | Aardvark Therapeutics, Inc. | $149.04M | Small cap | −24.25% |
| OCC.AX | Orthocell Limited | $148.74M | Small cap | −36.67% |
| CRNO-B.ST | Cereno Scientific AB (publ) | $148.23M | Small cap | −53.59% |
| KRMD | KORU Medical Systems, Inc. | $148.21M | Small cap | −24.47% |
| MIST | Milestone Pharmaceuticals Inc. | $146.91M | Small cap | −33.33% |
| LENZ | LENZ Therapeutics, Inc. | $146.73M | Small cap | −87.21% |
| OPRX | OptimizeRx Corporation | $145.98M | Small cap | −55.79% |
| INDP | Indaptus Therapeutics, Inc. | $145.90M | Small cap | −82.19% |
| STXS | Stereotaxis, Inc. | $145.29M | Small cap | −49.48% |
| TLSA | Tiziana Life Sciences Ltd | $138.71M | Small cap | −41.08% |
| SCLP.L | Scancell Holdings plc | $136.80M | Small cap | −7.62% |
| 004310.KS | Hyundai Pharmaceutical Co., Ltd. | $135.03M | Small cap | +51.26% |
| INO | Inovio Pharmaceuticals, Inc. | $134.42M | Small cap | −47.15% |
| ADCT | ADC Therapeutics SA | $134.05M | Small cap | −67.39% |
| ENGN | enGene Therapeutics Inc. | $130.63M | Small cap | −55.07% |
| BDTX | Black Diamond Therapeutics, Inc. | $130.42M | Small cap | −20.91% |
| CBUS | Cibus, Inc. | $128.40M | Small cap | +27.27% |
| QTRX | Quanterix Corporation | $126.75M | Small cap | −41.87% |
| GUTS | Fractyl Health, Inc. | $124.77M | Small cap | −25.55% |
| GNLX | Genelux Corporation | $123.52M | Small cap | −25.00% |
| DXB.AX | Dimerix Limited | $122.97M | Small cap | −34.83% |
| NTHI | NeOnc Technologies Holdings, Inc. | $122.16M | Small cap | −29.30% |
| ONE.AX | Oneview Healthcare PLC | $120.16M | Small cap | −15.56% |
| HCAT | Health Catalyst, Inc. | $118.91M | Small cap | −56.91% |
| RANI | Rani Therapeutics Holdings, Inc. | $118.23M | Small cap | +49.45% |
| QUCY | Quantum Cyber N.V. | $115.59M | Small cap | −15.12% |
| GBT.PA | Guerbet SA | $113.51M | Small cap | −61.92% |
| NAUT | Nautilus Biotechnology, Inc. | $111.99M | Small cap | +33.34% |
| FARON.HE | Faron Pharmaceuticals Oy | $111.17M | Small cap | −79.42% |
| FARN.L | Faron Pharmaceuticals Oy | $110.28M | Small cap | −79.24% |
| BNR | Burning Rock Biotech Limited | $110.10M | Small cap | +22.54% |
| HBP.TO | Helix BioPharma Corp. | $106.76M | Small cap | +46.97% |
| BGM | BGM Group Ltd. | $106.17M | Small cap | −96.61% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | $105.23M | Small cap | −60.78% |
| EAPI.PA | Euroapi S.A. | $104.85M | Small cap | −68.63% |
| MBOT | Microbot Medical Inc. | $102.09M | Small cap | −62.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.